HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation

Transplant Proc. 1993 Feb;25(1 Pt 2):1043-6.

Authors

A M Castelao¹, J M Griñó, E Andrés, S Gilvernet, D Serón, M J Castiñeiras, M Roca, J M Galcerán, M T González, J Alsina

Affiliation

¹ Department of Nephrology, Ciutat Sanitaria de Bellvitge, Hospital Prínceps d'Espanya, University of Barcelona.

PMID: 8442035

No abstract available

Publication types

Clinical Trial
Comparative Study

MeSH terms

Adult
Anticholesteremic Agents / therapeutic use*
Apolipoproteins / blood
Body Mass Index
Body Weight
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Hypercholesterolemia / drug therapy*
Hypercholesterolemia / etiology
Hypercholesterolemia / physiopathology
Immunosuppression Therapy / methods
Kidney Transplantation*
Lipids / blood*
Lipoproteins / blood
Lovastatin / analogs & derivatives*
Lovastatin / therapeutic use*
Male
Postoperative Complications / drug therapy*
Proteinuria
Simvastatin
Triglycerides / blood

Substances

Anticholesteremic Agents
Apolipoproteins
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids
Lipoproteins
Triglycerides
Lovastatin
Simvastatin